Developing blood tests for early cancer detection using DNA markers
Administrative Core
This study is working on developing blood tests that can help find cancer early by looking at changes in DNA, and it's being done by a team of experts to make sure the tests are reliable and useful for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10902049 on NIH RePORTER |
What this research studies
This research focuses on creating and validating blood-based biomarkers that can help detect cancer early. A team of experts from three leading cancer centers will collaborate to develop these tests, which involve analyzing DNA methylation patterns in blood samples. The project aims to streamline the process from initial discovery to clinical application, ensuring that the tests are reliable and effective for patient use. By coordinating efforts across multiple institutions, the research seeks to enhance the accuracy and efficiency of cancer detection methods.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for cancer or those undergoing routine cancer screenings.
Not a fit: Patients with cancers that are not detectable through blood-based biomarkers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and earlier detection of cancers, improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in using DNA methylation biomarkers for cancer detection, indicating a potential for success in this approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Herman, James G. — University of Pittsburgh at Pittsburgh
- Study coordinator: Herman, James G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.